Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 355134-13-3 | 3-Bromo-5-nitrobenzaldehyde | C7H4BrNO3 |
| 355386-94-6 | 5-Quinolineboronic acid;Quinoline-5-boronic acid | C9H8BNO2 |
| 355423-16-4 | 4-Bromo-2-fluoro-5-nitrobenzoic acid | C7H3BrFNO4 |
| 355806-00-7 | tert-Butyl rosuvastatin;tert-Butyl (6E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoate; (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[(methanesulfonyl)methylamino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid tert-butyl ester | C26H36FN3O6S |
| 355829-23-1 | 2-Chloro-5-fluoro-N,N-dimethyl-4-pyrimidinamine;(2-Chloro-5-fluoropyrimidin-4-yl)dimethylamine; 2-Chloro-4-(dimethylamino)-5-fluoropyrimidine | C6H7ClFN3 |
| 355832-04-1 | N-(9,9-Dimethylfluoren-2-yl)aniline;2-(Phenylamino)-9,9-dimethylfluorene | C21H19N |
| 355836-08-7 | 2-Methoxy-4,6-dimethylbenzeneboronic acid;4,6-Dimethyl-2-methoxybenzeneboronic acid | C9H13BO3 |
| 355836-10-1 | 2-Methoxy-4-trifluoromethoxyphenylboronic acid | C8H8BF3O4 |
| 356057-34-6 | Darapladib;SB 435445; SB 480848; N-[2-(Diethylamino)ethyl]-N-[4'-(trifluoromethyl)-1,1'-biphenyl-4-ylmethyl]-2-[2-(4-fluorobenzylthio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl]acetamide | C36H38F4N4O2S |
| 356068-86-5 | N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide | C14H23N3O2 |
| 356068-93-4 | 5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | C16H13FN2O3 |
| 356068-94-5 | Toceranib;PHA 291639; SU 11654; 5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide | C22H25FN4O2 |
| 356068-97-8 | N-Desethyl-sunitinib;5-[((3Z)-5-Fluoro-2-oxo-1,2-dihydroindol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-ethylaminoethyl)amide | C20H23FN4O2 |
| 356559-20-1 | SB 525334;6-[2-(1,1-Dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline | C21H21N5 |
| 356560-80-0 | 6-Bromo-[1,2,4]triazolo[1,5-a]pyridine | C6H4BrN3 |
| 356560-84-4 | 1-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-2-(6-methylpyridin-2-yl)ethane-1,2-dione | C14H10N4O2 |
| 356570-52-0 | 4-Methylbenzylboronic acid pinacol ester;4,4,5,5-Tetramethyl-2-(4-methylbenzyl)-1,3,2-dioxaborolane | C14H21BO2 |
| 356572-08-2 | 1-Hydroxy-3-amino-5,7-dimethyladamantane hydrochloride | C12H21NO.HCl |
| 356783-16-9 | 3,6-Dichloro-2-pyrazinecarbonitrile | C5HCl2N3 |
| 356783-28-3 | 3,6-Difluoro-2-pyrazinecarbonitrile | C5HF2N3 |
| 356786-94-2 | Pantothenic acid-<sup>13</sup>C<sub>4</sub>,<sup>15</sup>N hemicalcium salt;N-[(2R)-2,4-Dihydroxy-3,3-dimethyl-1-oxobutyl]-β-alanine-13C3,15N Hemicalcium | 13C6C12H32Ca15N2O10 |
| 357166-29-1 | Pemetrexed disodium hepthydrate;N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt hydrate | C20H19N5Na2O6.7(H2O) |
| 357166-30-4 | Pemetrexed disodium hydrate;N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt hydrate | 2(C20H19N5Na2O6).5(H2O) |
| 357189-94-7 | Posaconazole 3-OXO impurity;2-[(1S,2S)-1-Ethyl-2-hydroxypropyl]-4-[4-[2-oxo-4-[4-[[(3R)-5-(2,4-difluorophenyl)-5beta-(1H-1,2,4-triazole-1-ylmethyl)tetrahydrofuran-3beta-yl]methoxy]phenyl]piperazino]phenyl]-2,4-dihydro-3H-1,2,4-triazole-3-one | C37H40F2N8O5 |
| 357189-95-8 | Posaconazole Impurity B;N-[2-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]-N-formylanilino]ethyl]-N-[4-[1-[(2S,3S)-2-hydroxypentan-3-yl]-5-oxo-1,2,4-triazol-4-yl]phenyl]formamide | C37H40F2N8O6 |
| 357209-32-6 | 2,6-Bis[(3aR,8aS)-(+)-8H-indeno[1,2-d]oxazolin-2-yl)pyridine | C25H19N3O2 |
| 357219-41-1 | 9,9-Bis(2-ethylhexyl)fluorene-2,7-bis(boronic acid pinacol ester);9,9-Bis(2-ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)fluorene | C41H64B2O4 |
| 357263-13-9 | BMS 378806;BMS 806; 1-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,2-ethanedione | C22H22N4O4 |
| 357263-40-2 | 4-Methoxy-1H-pyrrolo[2,3-c]pyridine;4-Methoxy-6-azaindole | C8H8N2O |
| 357263-41-3 | 7-Chloro-1H-pyrrolo[2,3-c]pyridine | C7H5ClN2 |
| 357263-42-4 | 7-Methyl-4-azaindole;7-Methyl-1H-pyrrolo[3,2-b]pyridine | C8H8N2 |
| 357263-43-5 | 5-Chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine;5-Chloro-7-methyl-4-azaindole | C8H7ClN2 |
| 357263-48-0 | 7-Chloro-1H-pyrrolo[3,2-b]pyridine | C7H5ClN2 |
| 357263-49-1 | Methyl 7-azaindole-3-glyoxylate;Methyl (7-azaindol-3-yl)oxoacetate | C10H8N2O3 |
| 357274-85-2 | [1-(Trifluoromethyl)vinyl]boronic acid;(3,3,3-Trifluoroprop-1-en-2-yl)boronic acid | C3H4BF3O2 |
| 357289-65-7 | 4-Cyanofuran-2-carboxylic acid methyl ester | C7H5NO3 |
| 357336-20-0 | Brivaracetam;(alphaS,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide; UCB-34714 | C11H20N2O2 |
| 357336-99-3 | Brivaracetam (alfaR, 4S)-Isomer;(2R)-2-[(4S)-2-Oxo-4-propyl-1-pyrrolidinyl]butanamide | C11H20N2O2 |
| 357338-13-7 | (alphaS)-alpha-Ethyl-2,5-dihydro-2-oxo-4-propyl-1H-pyrrole-1-acetamide | C11H18N2O2 |
| 357399-43-0 | 2-Hydroxy-2-(3-chlorophenyl)-3,5,5-trimethylmorpholine | C13H18ClNO2 |
| 357405-75-5 | 4-Bromo-2,5-difluorobenzaldehyde | C7H3BrF2O |
| 357426-12-1 | 3-(Aminomethyl)-2,3-dihydro-1H-indene-1-carboxylic acid methyl ester | C12H15NO2 |
| 357437-74-2 | 3,6-Dibromo-9-(4-methylphenyl)-9H-carbazole | C19H13Br2N |
| 357645-16-0 | 6-Hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxy-3,4-dihydro-2-naphthaldehyde | C20H20O6 |
| 357645-37-5 | 2,7-Dibromo-9,9-bis(4-methylphenyl)-9H-fluorene | C27H20Br2 |
| 357645-40-0 | N2,N7-Di-1-naphthalenyl-N2,N7,9,9-tetraphenyl-9H-fluorene-2,7-diamine | C57H40N2 |
| 357927-50-5 | 2-Bromo-4-fluoropyridine | C5H3BrFN |
| 358629-47-7 | (alphaZ)-alpha-Ethylidene-2-oxo-1-pyrrolidineacetamide | C8H12N2O2 |
| 358672-65-8 | 5-Bromo-6-chloropyridin-2-amine;6-Amino-2-chloro-3-bromopyridine | C5H4BrClN2 |
| 358748-29-5 | (4R,5S,6S)-5-(Acetyloxy)-4-(benzoyloxy)-6-[(benzoyloxy)methyl]-6-hydroxy-2-cyclohexen-1-one | C23H20O8 |